DNA aptamer biosensors for lactate detection

Summary of the technology

Background

With limited oxygen, anaerobic glycolysis occurs to convert glucose to lactate. Athletes are keen to monitor lactate to stay in the aerobic metabolic state. A high level of lactate is also an indication of a variety of physiological and pathological conditions such as sepsis and heart attack, acidosis and cancer. More recently plasma lactate has been strongly associated with type 2 diabetes in older adults. The global serum lactate testing market is projected to grow at a CAGR of 7% reaching a value of $US 1.04 B by 2026.

Additionally, measurement of lactate is important in the food industry to monitor fermentation, bacterial contamination and wine production.

The detection of lactate has been traditionally carried out using enzymes namely lactate oxidase (LOx) and lactate dehydrogenase (LDH). LOx produces H2O2 as a co-product for indirect detection. LDH requires NAD+ as an electron acceptor. The reliability and sensitivity of such enzyme-based biosensors is affected by enzyme activity, denaturation, and the concentration of oxygen or NAD+, making calibration difficult.

University of Waterloo
University of Waterloo

Description of the invention

Aptamers are single-stranded nucleic acids and they have been shown to bind to a diverse range of target molecules. Unlike enzymes, aptamers rely solely on binding for target recognition and are independent of other reactants such as oxygen or NAD+. In this invention, an aptamer is produced to bind lactate with a dissociation constant of ~0.4 mM with excellent selectivity. Simultaneous detection of both lactate and glucose in a serum solution was achieved using the two sensors labeled with different fluorophores. The figure on the top left corner shows the diagram of the detection of both lactate and glucose in the same sample. The sensors had instantaneous responses. They can work even in 90% human blood serum.

Advantages

The aptamer-based technology can allow direct, rapid and continuous monitoring of lactate concentration. It is a totally different technology compared to the current enzyme-based assays. It will allow more robust, simpler and more cost-effective detection.

Potential applications

  • Wearable biosensors for continuous lactate monitoring (athletes).
  • Hospital emergency room (sepsis diagnosis).
  • Bacterial infection diagnosis
  • Lactate acidosis diagnosis
  • Diabetes (Type 2) diagnosis and monitoring
  • Food industry, fermentation, wine production.

Related Keywords

  • Life & Physical Sciences
  • Health care

About University of Waterloo

The University of Waterloo, renowned for its innovative spirit and co-op education model, excels in cutting-edge research across diverse fields, including advanced manufacturing, artificial intelligence, sustainability, and health technologies.

University of Waterloo

Never miss an update from University of Waterloo

Create your free account to connect with University of Waterloo and thousands of other innovative organizations and professionals worldwide

University of Waterloo

Send a request for information
to University of Waterloo

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support